U.S., July 9 -- ClinicalTrials.gov registry received information related to the study (NCT07054801) titled 'IA Lidocaine and Methylprednisolone for Headache Associated With Subarachnoid Hemorrhage' on June 27.
Brief Summary: Subarachnoid hemorrhage (SAH) is a type of bleeding around the brain that can cause sudden and severe headaches. These headaches can be debilitating and persist for weeks, significantly impacting a patient's comfort and recovery. Many patients require opioids for pain control, which can lead to side effects such as drowsiness, constipation, and dependency. There is a need for new treatment strategies to help relieve this pain while minimizing side effects.
This clinical study is designed to evaluate whether an injecti...